Kayne Anderson Rudnick Investment Management LLC Sells 5,831 Shares of Equifax, Inc. $EFX

Key Points

• Kayne Anderson Rudnick Investment Management LLC holds approximately $759 million in Equifax, representing 1.9% of its portfolio after a slight reduction in shares.
• Equifax's CEO, Mark W. Begor, sold 48,264 shares at about $241.71 each, decreasing his stake by 25.25%.
• Analysts have mixed views on Equifax, with revisions to price targets ranging from $240 to $295, while the stock holds a consensus rating of "Moderate Buy."

Kayne Anderson Rudnick Investment Management LLC decreased its holdings in Equifax, Inc. (NYSE:EFX - Free Report) by 0.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,117,870 shares of the credit services provider's stock after selling 5,831 shares during the period. Equifax comprises approximately 1.9% of Kayne Anderson Rudnick Investment Management LLC's investment portfolio, making the stock its 6th biggest holding. Kayne Anderson Rudnick Investment Management LLC owned approximately 2.51% of Equifax worth $759,388,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. True Wealth Design LLC raised its stake in Equifax by 1,920.0% in the fourth quarter. True Wealth Design LLC now owns 101 shares of the credit services provider's stock valued at $26,000 after buying an additional 96 shares during the period. Ameriflex Group Inc. bought a new stake in Equifax in the fourth quarter valued at approximately $28,000. N.E.W. Advisory Services LLC bought a new stake in Equifax in the first quarter valued at approximately $28,000. Colonial Trust Co SC raised its stake in Equifax by 505.0% in the fourth quarter. Colonial Trust Co SC now owns 121 shares of the credit services provider's stock valued at $31,000 after buying an additional 101 shares during the period. Finally, Zions Bancorporation National Association UT bought a new stake in Equifax in the first quarter valued at approximately $32,000. Institutional investors own 96.20% of the company's stock.

Analysts Set New Price Targets

Several research firms have issued reports on EFX. Morgan Stanley restated an "overweight" rating and issued a $305.00 price objective (up previously from $295.00) on shares of Equifax in a research note on Tuesday, June 10th. BMO Capital Markets lowered their target price on Equifax from $280.00 to $260.00 and set a "market perform" rating on the stock in a research note on Wednesday, July 23rd. Robert W. Baird lowered their target price on Equifax from $310.00 to $289.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 23rd. Wells Fargo & Company lowered their target price on Equifax from $310.00 to $300.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 23rd. Finally, Bank of America lowered Equifax from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $300.00 to $285.00 in a research note on Monday, June 23rd. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Equifax currently has a consensus rating of "Moderate Buy" and a consensus target price of $283.53.

Insider Buying and Selling at Equifax

In other Equifax news, CEO Mark W. Begor sold 48,264 shares of the firm's stock in a transaction on Monday, July 28th. The stock was sold at an average price of $241.71, for a total value of $11,665,891.44. Following the sale, the chief executive officer owned 142,872 shares of the company's stock, valued at approximately $34,533,591.12. This trade represents a 25.25% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.40% of the company's stock.

Equifax Price Performance

Equifax stock traded down $3.20 during mid-day trading on Tuesday, reaching $247.56. 749,834 shares of the company were exchanged, compared to its average volume of 1,055,440. The company has a fifty day simple moving average of $252.15 and a 200-day simple moving average of $250.27. The firm has a market cap of $30.65 billion, a PE ratio of 48.45, a PEG ratio of 3.02 and a beta of 1.64. Equifax, Inc. has a 12 month low of $199.98 and a 12 month high of $309.63. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.77 and a quick ratio of 0.77.

Equifax (NYSE:EFX - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share for the quarter, beating analysts' consensus estimates of $1.92 by $0.08. The firm had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.51 billion. Equifax had a return on equity of 18.89% and a net margin of 10.95%.The company's revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.82 EPS. Equifax has set its Q3 2025 guidance at 1.870-1.970 EPS. FY 2025 guidance at 7.330-7.630 EPS. As a group, equities research analysts expect that Equifax, Inc. will post 7.58 earnings per share for the current fiscal year.

Equifax Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Tuesday, September 2nd will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 2nd. Equifax's dividend payout ratio (DPR) is currently 39.14%.

Equifax Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.